A kind of roxburghii functional ingredient composition and its preparation method and application

By optimizing the functional component extraction process of ulceric pear, a composition containing polysaccharides and small molecule active substances was prepared, which solved the problem of low utilization value of ulceric pear, achieved effective relief of ulcerative colitis and promoted product development, and improved the Its economic value.

CN116617303BActive Publication Date: 2024-11-08INNOVATION CENTER OF YANGTZE RIVER DELTA ZHEJIANG UNIVERSITY +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310668830.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-06-07
Publication Date
2024-11-08
Estimated Expiration
2043-06-07

AI Technical Summary

Technical Problem

The functional component extraction process and application of sacred pear are relatively lacking, resulting in low comprehensive utilization value and lack of high-precision deep processing products, which limits its economic value in medical processing, especially in the treatment of ulcerative colitis. Solution.

Method used

A functional ingredient composition of ingredient, including ingredient polysaccharide and small molecule active substances, was developed, and prepared by reflux of ethanol aqueous solution, cellulase leaching, ultrasonic extraction and macroporous resin purification, and the extraction process was optimized. The composition has a better effect of relieving ulcerative colitis and blocks the sour taste of fresh fruits.

Benefits of technology

It has achieved the enrichment and functional retention of the functional components of the uricidal pear, provided a more effective relief effect of ulcerative colitis, promoted the development of the uricidal pear product and the development of the high-precision deep processing industry, and improved its economic value in medical processing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116617303B_ABST
    Figure CN116617303B_ABST
Patent Text Reader

Abstract

The present invention provides a composition of functional ingredients of roxburghii roxburghii, and a preparation method and application thereof, and belongs to the technical field of natural active ingredient extraction. The present invention provides a composition of functional ingredients of roxburghii roxburghii, comprising roxburghii roxburghii polysaccharides and roxburghii roxburghii small molecule active substances; the mass ratio of the roxburghii roxburghii polysaccharides to the roxburghii roxburghii small molecule active substances is 1-3:1-3. The present invention extracts a composition of roxburghii roxburghii polysaccharides and small molecule active substances that can relieve ulcerative colitis, shields the original sour and astringent taste of the fresh fruit and retains its functional ingredients as much as possible, and achieves a better effect of relieving ulcerative colitis than the whole fruit. Therefore, the present invention improves the comprehensive utilization value of roxburghii roxburghii raw materials and the economic value in pharmaceutical processing, and the extraction process conditions are simple and efficient, and the operation is convenient.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of natural active ingredient extraction, and particularly relates to a roxburghii roxburghii functional ingredient composition and a preparation method and application thereof. Background Art

[0002] Rosa roxburghii, also known as seedless roxburghii, is a medicinal and edible plant of the genus Rosa in the Rosaceae family. It is a new and unique variety discovered by Guizhou Botanical Garden more than 30 years ago. It is named because its stamens are aborted and its fruit is seedless. Rosa roxburghii mainly grows in hilly and mountainous areas at an altitude of 1,000 to 1,600 meters. It is an important wild resource in southwest, central and northwestern provinces of China. Rosa roxburghii fruit is rich in vitamin C, SOD, polysaccharides, phenolic substances, β-carotene, zeaxanthin, trace elements, amino acids, triterpenes and other active substances. It is a third-generation fruit and can be used as a medical auxiliary food. However, its fruit has a poor taste when eaten fresh, and is sour and astringent, and its acceptance is low, resulting in a small consumption and limited development prospects.

[0003] At present, there is a lack of research on golden roxburghii, which mainly focuses on the analysis of its kinship, fruit traits and nutritional components, but less on the extraction process and application of its functional ingredients. Product development is also in its infancy, resulting in low comprehensive utilization value of golden roxburghii and lack of high-precision processed products, thus limiting the economic value of golden roxburghii fruit in medical processing.

[0004] In addition, ulcerative colitis is a nonspecific chronic inflammatory disease with lesions in the colon and rectum. At present, the pathogenesis of ulcerative colitis is still unclear and the etiology is complex. It is mainly treated by drugs, but conventional drugs have serious adverse reactions. Finding and developing new therapeutic agents without toxic side effects is of great significance to the relief or treatment policy of ulcerative colitis. There are currently no reports on the use of plant extracts to treat ulcerative colitis. Summary of the invention

[0005] In view of this, the object of the present invention is to provide a Rosa roxburghii functional ingredient composition to alleviate the effect of ulcerative colitis.

[0006] The invention provides a roxburghii roxburghii functional ingredient composition, comprising roxburghii roxburghii polysaccharide and roxburghii ... small molecule active substances;

[0007] The mass ratio of the roxburghii roxburghii polysaccharide to the roxburghii roxburghii small molecule active substance is 1-3:1-3.

[0008] Preferably, the roxburghii polysaccharide comprises the following components in molar percentage: 0-1% fucose, 6-7% rhamnose, 10-11% arabinose, 26-27% galactose, 7-8% glucose, 1-2% mannose, 44-45% galacturonic acid and 2-3% glucuronic acid.

[0009] Preferably, the small molecule active substances of Rosa roxburghii include ascorbic acid, Plucheoside C, epicatechin, catechin derivatives, epicatechin derivatives, Prehygromycin, 1-OE-cinnamoyl-(6-arabinosyl glucose), ellagic acid-O-rhamnoside, quercetin-3-O-β-D-glucoside-6″-(E)-p-coumaryl-glucoside and chokeberryside F1.

[0010] The present invention provides a method for preparing the functional component composition of Rosa roxburghii, comprising the following steps:

[0011] The fresh fruit of Rosa roxburghii is dried and crushed, and then refluxed with ethanol water solution, the reflux liquid is solution A, and the ethanol is removed from the residue;

[0012] The residue after removing ethanol is extracted with an aqueous solution containing cellulase to obtain enzymatic residue and an extract, after removing protein and pigment impurities from the extract, polysaccharide is collected by alcohol precipitation to obtain Rosa roxburghii polysaccharide;

[0013] The enzymatic residue is subjected to ultrasonic extraction with an ethanol aqueous solution, and the extract is collected to obtain a solution B;

[0014] The solution A and the solution B are mixed and purified, and after removing water, a small molecule active substance of Rosa roxburghii is obtained;

[0015] The roxburghii roxburghii polysaccharide and the roxburghii roxburghii small molecule active substance are compounded to obtain the roxburghii roxburghii functional ingredient composition.

[0016] Preferably, during reflux, the volume percentage of the ethanol aqueous solution is 70-95%.

[0017] Preferably, during the extraction, the solid-liquid ratio of the ethanol-removed residue and the aqueous solution containing cellulase is 1 g: 20-40 mL; the final mass percentage of the cellulase is 1%-5%;

[0018] The enzymatic hydrolysis temperature of the cellulase is 40-60° C., and the enzymatic hydrolysis time of the cellulase is 80-150 min.

[0019] Preferably, during the alcohol precipitation, the volume percentage of the alcohol solution is 80% to 95%.

[0020] Preferably, during ultrasonic extraction of ethanol aqueous solution, the volume percentage of the ethanol aqueous solution is 70% to 95%, the liquid-to-solid ratio of the enzymatic hydrolysis residue and the ethanol aqueous solution is 1:10 to 30, the time of ultrasonic extraction of the ethanol aqueous solution is 20 to 50 minutes, the temperature of ultrasonic extraction of the ethanol aqueous solution is 40 to 60°C, and the frequency of the ultrasound is 30 to 50 kHz.

[0021] Preferably, the method for purifying the mixture of solution A and solution B is purification using a macroporous resin;

[0022] In the purification method of the macroporous resin, the loading volume of the mixed solution of solution A, solution B and solution C is 0.5 to 2 times the column volume, the flow rate is 1 to 3 mL / min, the detergent is 8 to 15 times the column volume of distilled water, and the desorbent is an ethanol aqueous solution with a volume percentage of 70% to 95%.

[0023] The present invention provides application of the functional ingredient composition of golden roxburghii or the functional ingredient composition of golden roxburghii obtained by the preparation method in preparing a healthy food having the function of preventing or alleviating ulcerative colitis.

[0024] The present invention provides a roxburghii roxburghii functional ingredient composition, comprising roxburghii roxburghii polysaccharides and roxburghii roxburghii small molecule active substances; the mass ratio of the roxburghii roxburghii polysaccharides to the roxburghii roxburghii small molecule active substances is 1-3:1-3. Experiments have shown that the roxburghii roxburghii functional ingredient composition provided by the present invention has a better effect of alleviating ulcerative colitis than the whole roxburghii roxburghii fruit, and plays a role in enriching functional ingredients. In addition, the composition obtained by the present invention shields the original sour and astringent taste of the fresh fruit and retains its functional ingredients as much as possible, so as to directly obtain its nutritional value. The present invention provides a new direction for the development of roxburghii roxburghii products, promotes the development of the high-precision and deep processing industry of roxburghii roxburghii, and improves the economic value of roxburghii roxburghii fruit in medical processing.

[0025] The invention provides a method for preparing the functional component composition of golden roxburghii, which utilizes a set of comprehensive extraction processes to simultaneously obtain two types of functional components in golden roxburghii, thereby greatly improving process efficiency. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is a comprehensive extraction process flow chart of a compound of functional components of Rosa roxburghii;

[0027] Figure 2 This is the gel chromatogram of the molecular weight of the polysaccharide of Rosa roxburghii;

[0028] Figure 3 This is the ion chromatogram of the monosaccharide composition of the golden roxburghii polysaccharide;

[0029] Figure 4 This is the liquid phase diagram of the small molecule active substances of Rosa roxburghii;

[0030] Figure 5 This is a curve chart showing the effects of the compound of functional ingredients of Rosa roxburghii and the whole fruit on the body weight of mice with ulcerative colitis;

[0031] Figure 6 It is a scatter plot of the effects of the compound of functional ingredients of Rosa roxburghii and the whole fruit on the DAI score of mice with ulcerative colitis on the 11th day;

[0032] Figure 7 It is a bar graph showing the effects of the compound of functional ingredients of Rosa roxburghii and the whole fruit on the colon length of mice with ulcerative colitis;

[0033] Figure 8 This is a bar graph showing the effects of the compound of functional ingredients of Rosa roxburghii and the whole fruit on the spleen index of mice with ulcerative colitis;

[0034] Fig. 9 This is a picture showing the staining observation of the colon tissue pathology of mice with ulcerative colitis by the compound of the functional ingredients of Rosa roxburghii and the whole fruit.

[0035] Fig.10 It is a bar graph showing the effects of the compound of functional ingredients of Rosa roxburghii and the whole fruit on the content of short-chain fatty acids in mice with ulcerative colitis;

[0036] Fig.11 This is a bar graph showing the effects of the compound of functional ingredients of Rosa roxburghii and the whole fruit on the intestinal permeability of mice with ulcerative colitis.

[0037] Fig.12 This is a bar graph showing the effects of a combination of functional ingredients of Rosa roxburghii and the whole fruit on serum inflammatory factors in mice with ulcerative colitis. DETAILED DESCRIPTION

[0038] The invention provides a roxburghii roxburghii functional ingredient composition, comprising roxburghii roxburghii polysaccharide and roxburghii ... small molecule active substances;

[0039] The mass ratio of the roxburghii roxburghii polysaccharide to the roxburghii roxburghii small molecule active substance is 1-3:1-3.

[0040] In the present invention, the golden roxburghii polysaccharide preferably includes the following components in molar percentage: 0-1% fucose, 6%-7% rhamnose, 10%-11% arabinose, 26%-27% galactose, 7%-8% glucose, 1%-2% mannose, 44%-45% galacturonic acid and 2%-3% glucuronic acid.

[0041] The small molecule active substances of Rosa roxburghii preferably include ascorbic acid, Plucheoside C, catechin, epicatechin, catechin derivatives, epicatechin derivatives, Prehygromycin, 1-OE-cinnamoyl-(6-arabinosyl glucose), ellagic acid-O-rhamnoside, quercetin-3-O-β-D-glucoside-6″-(E)-p-coumaryl-glucoside and chokeberry glycoside F1.

[0042] In the present invention, the method for extracting polysaccharides from Rosa roxburghii preferably comprises the following steps:

[0043] The fresh fruit of the golden roxburghii is dried and ground, and then refluxed with an ethanol-water solution. After removing ethanol from the obtained residue, the residue is extracted with a solution containing cellulase, protein and pigment impurities are removed from the obtained extract, and polysaccharides are collected by an alcohol precipitation method to obtain the golden roxburghii polysaccharide.

[0044] In the present invention, the volume percentage of the ethanol aqueous solution during the reflux is 70% to 95%, more preferably 80 to 90%, and most preferably 85%. The number of refluxes is preferably 1 to 3 times. The method for removing ethanol is preferably to naturally air-dry the residue.

[0045] In the present invention, during the extraction, the material-water ratio of the residue after removing ethanol and the solution containing cellulase is preferably 1:20 to 1:40 (g / mL), more preferably 1:30 (g / mL). The final mass percentage of cellulase in the solution containing cellulase is preferably 1% to 5%, more preferably 2% to 4%, and most preferably 3%. The enzymolysis temperature of the cellulase is preferably 40 to 60°C, more preferably 50°C. The enzymolysis time of the cellulase is preferably 80 to 150 min, more preferably 100 to 120 min.

[0046] In the present invention, after extraction, the present invention preferably concentrates the extract. The method of concentration is preferably rotary evaporation. The temperature of the rotary evaporation is preferably 40 to 55°C, more preferably 45 to 50°C, and most preferably 50°C. The rotary evaporation is preferably terminated when the evaporation reaches 1 / 4 to 1 / 3 of the original volume. The method of removing protein is preferably trichloroacetic acid method. The method of removing pigment is preferably decolorization with AB-8 macroporous resin. The volume ratio of the macroporous resin to the extract is 1:5 to 1:8, more preferably 1:(6 to 7). During the alcohol precipitation, the volume percentage of the alcohol aqueous solution is preferably 80% to 95%. The alcohol is preferably ethanol. The alcohol aqueous solution is twice the volume of the extract for removing protein and pigment impurities. The alcohol precipitation time is preferably 5 to 12h, more preferably 10h. After the alcohol precipitation, it is also preferred to remove small molecule polysaccharides and remove water. The method of removing small molecules is preferably to redissolve the precipitate obtained by alcohol precipitation with water and then dialyze. The dialysis bag for dialysis is preferably a 5-10 kDa dialysis bag, and the method for removing moisture is preferably vacuum freeze drying. The vacuum drying temperature is preferably -40 to -75°C.

[0047] In the present invention, it is determined that the molecular weight of the golden roxburghii polysaccharide is 600-700 kDa, and it is composed of fucose, rhamnose, arabinose, galactose, glucose, mannose, galacturonic acid and glucuronic acid, and the molar percentage contents are 0-1%, 6-7%, 10-11%, 26-27%, 7-8%, 1-2%, 44-45% and 2-3%, respectively.

[0048] In the present invention, the method for preparing the small molecule active substance of Rosa roxburghii preferably comprises the following steps:

[0049] The fresh fruit of Rosa roxburghii is refluxed through an ethanol aqueous solution to obtain a reflux solution as solution A;

[0050] The filter residue obtained after reflux is hydrolyzed and extracted by cellulase, and the enzymatic hydrolysis filter residue is collected and ultrasonically extracted with ethanol aqueous solution, and the obtained extract is solution B;

[0051] The solution A and the solution B are mixed and purified to obtain the small molecule active substance of Rosa roxburghii.

[0052] In the present invention, the number of reflux is preferably 1 to 3 times. The separation method of the reflux liquid is suction filtration.

[0053] In the present invention, during ultrasonic extraction of ethanol aqueous solution, the volume percentage of the ethanol aqueous solution is preferably 70% to 95%, more preferably 75% to 90%, and most preferably 85%. The liquid-to-solid ratio of the enzymatic residue and the ethanol aqueous solution is preferably 1:10 to 30, more preferably 1:20. The time for ultrasonic extraction of the ethanol aqueous solution is preferably 20 to 50 minutes, more preferably 30 to 40 minutes, and most preferably 35 minutes. The temperature for ultrasonic extraction of the ethanol aqueous solution is preferably 40 to 60°C, more preferably 50°C. The frequency of the ultrasound is preferably 30 to 50kHz, more preferably 40kHz. The ultrasonic extraction is preferably performed twice. After the first ultrasonic extraction, the residue and solution B are separated, and the residue is ultrasonically extracted again, the liquid phase is separated, and mixed with solution B.

[0054] In the present invention, the method for purifying the mixture of solution A and solution B is preferably purified by macroporous resin. In the purification method of macroporous resin, the loading volume of the mixture of solution A and solution B is 0.5 to 2 times the column volume, more preferably 1 to 1.5 times the column volume. The flow rate of the sample is preferably 1 to 3 mL / min, more preferably 2 mL / min. The detergent is preferably 8 to 15 times the column volume of distilled water, more preferably 10 to 12 times the column volume of distilled water, and the desorbent is an ethanol aqueous solution with a volume percentage of 70% to 95%. After the purification, it is preferably also included to remove water. The method for removing water is preferably rotary evaporation and freeze drying.

[0055] In the present invention, the components of the extracted small molecule active substances detected by LC-MS are mainly ascorbic acid, Plucheoside C, catechin, epicatechin, catechin derivatives, epicatechin derivatives, Prehygromycin, 1-OE-cinnamoyl-(6-arabinosyl glucose), ellagic acid-O-rhamnoside, quercetin-3-O-β-D-glucoside-6″-(E)-p-coumaryl-glucoside and chokeberryside F1.

[0056] The present invention provides application of the functional ingredient composition of golden roxburghii or the functional ingredient composition of golden roxburghii obtained by the preparation method in preparing a healthy food having the function of preventing or alleviating ulcerative colitis.

[0057] In the present invention, the ulcerative colitis animal model is used as the experimental object, and the difference between the functional component composition of golden roxburghii and the whole fruit of golden roxburghii in relieving or treating ulcerative colitis is compared. The results show that the functional component composition of golden roxburghii can effectively reduce the disease index of mice, and has a significant effect compared with the whole fruit; the functional component composition of golden roxburghii has a relieving effect on the shortening of the mouse colon, and has a significant effect compared with the whole fruit; the functional component composition of golden roxburghii can effectively relieve the splenomegaly caused by DSS in mice, while the whole fruit has no obvious effect. The functional component composition of golden roxburghii can significantly reduce the crypt structure damage, goblet cell damage and inflammatory cell infiltration symptoms of DSS-induced ulcerative colitis mice, and has the potential to relieve the reduction of mucin expression. The functional component composition can relieve intestinal inflammation by promoting the production of short-chain fatty acids. The functional component composition can effectively relieve the intestinal barrier damage caused by DSS and maintain intestinal permeability. The functional component composition of golden roxburghii can effectively reduce the level of inflammatory factors in serum, relieve colon inflammation, and the relief effect is better than that of the whole fruit of golden roxburghii.

[0058] The following is a detailed description of a Rosa roxburghii functional ingredient composition provided by the present invention, a preparation method thereof and an application thereof, in conjunction with the embodiments, but they should not be construed as limiting the scope of protection of the present invention.

[0059] Example 1

[0060] A functional component composition of Rosa roxburghii and a comprehensive extraction process thereof, comprising the following steps:

[0061] (1) Wash the fresh fruit of Rosa roxburghii and dry it in a 40°C forced air drying oven for 36 h, then crush it with a grinder and pass it through a 60-mesh sieve;

[0062] (2) The obtained powder was refluxed with 70% ethanol solution in a 50° C. water bath for 1 h, filtered with suction, and the filtrate was collected. The filter residue was refluxed once again, filtered with suction, and the filtrate was collected. The filter residue was naturally air-dried at room temperature until there was no ethanol smell, and the golden roxburghii residue A was obtained. The two reflux solutions were combined into solution A.

[0063] (3) Add deionized water to the residue A of golden roxburghii at a liquid-solid ratio of 1:20 (g / mL), adjust the pH of the solution to 4.5, add cellulase and hydrolyze for 80 minutes in a constant temperature oscillator at 40°C (the amount of cellulase is 1%, and it is dissolved in 1:1 distilled water (g / mL) before use, and water bathed at the specified temperature for 5 minutes), and inactivate the enzyme in a water bath at 100°C for 10 minutes. After filtration, collect the supernatant and rotary evaporate it at 40°C to one-fourth to one-third of the original volume, and collect the filter residue as residue B for later use. Use trichloroacetic acid method to remove protein, add trichloroacetic acid to the filtrate to a final concentration of 3%, stand at 0°C for 10 hours, refrigerate centrifuge at 6000r / min for 5 minutes, discard the precipitate, repeatedly add trichloroacetic acid to the supernatant, stand and centrifuge until there is no precipitate. The clear solution is decolorized by AB-8 macroporous resin, the volume ratio of macroporous resin to extract is 1:5, and shake in a water bath at 30°C for 6 hours. After decolorization, the filtrate was collected, and two volumes of 80% ethanol were slowly added under stirring. After being placed in a refrigerator at 0°C overnight, the precipitate was collected and redissolved in distilled water at 6000r / min. The precipitate was dialyzed with a 5kDa dialysis bag. After the dialysis was completed, the solution was vacuum dried at -40°C to obtain the roxburghii polysaccharide, with a yield of 3%.

[0064] (4) The molecular weight of the polysaccharide was detected using the SEC-MALLS-RI system. A 0.15 mol / L NaCl solution (containing 0.02% NaN 3 ) as the mobile phase, pass through a 0.22μm water film, ultrasonically degas for 20min, and set aside. The sample was dissolved in 1mL of mobile phase, passed through a 0.22μm water film, and then tested. Detection conditions: flow rate 0.5mL / min, column temperature 25℃, injection volume 50μL, data collection 55min, refractive index increment dn / dc of 0.138mL / g. The molecular weight of the polysaccharide was measured to be 600kDa. The monosaccharide composition of the polysaccharide was determined by high-performance anion exchange chromatography-pulsed amperometry. The sample was dissolved in 1mL of deionized water, placed in a 10mL ampoule, 1mL of 4M trifluoroacetic acid was added, sealed with an alcohol burner, placed in a digestion instrument at 110℃ for 8h, and then cooled to room temperature. 1mL, 200μL, and 200μL of methanol were added to the sample three times, and each time was blown dry with nitrogen. The dried sample was dissolved in 6 mL of ultrapure water and chromatographically analyzed after passing through a 0.22 μm water film. The specific detection conditions were: column temperature: 30 °C; flow rate: 1 mL / min; injection volume: 25 μL; mobile phase and gradient elution program: 0-15 min, 18 mM NaOH; 15-50 min, 18 mM NaOH and 100 mM CH 3 COONa.

[0065] It was measured that the golden roxburghii polysaccharide is composed of fucose, rhamnose, arabinose, galactose, glucose, mannose, galacturonic acid and glucuronic acid, with the molar percentage contents being 0.52%, 6.44%, 10.21%, 26.35%, 7.11%, 1.12%, 44.87% and 2.56%, respectively.

[0066] (5) The residue B was treated with 70% ethanol aqueous solution at a liquid-to-solid ratio of 10:1, and ultrasonically extracted for 20 min (40°C, 30 kHz), and centrifuged (6000 r / min, 8 min, 0°C) to obtain supernatant B and precipitated residue C. The above steps were repeated for residue C, and solution C was obtained after centrifugation.

[0067] (6) Combine solutions A, B, and C, evaporate and concentrate at 35°C, and purify using AB-8 macroporous resin. Mix distilled water and resin and slowly add them to the column, wash with distilled water, and adjust the flow rate until the filling in the column is stable. Leave at least 5 cm from the top of the column to the resin, and seal the column with distilled water. The loading volume of the mixed solution is 0.5 times the column volume, the flow rate is 1 mL / min, first wash with 8 times the column volume of distilled water to remove soluble polysaccharides and proteins, and then use 70% ethanol to desorb the small molecules adsorbed on the resin, collect the desorbed liquid, rotary evaporate to obtain the concentrated liquid, transfer to a freeze dryer and dry for 36 hours to obtain the purified small molecule active substance, with a yield of 4%.

[0068] (7) LC-MS analysis showed that the main components of the small molecule active substance were ascorbic acid, Plucheoside C, (epi)catechin, (epi)catechin derivative, prehygromycin, 1-OE-Cinnamoyl-(6-arabinosylglucose), ellagic acid-O-rhamnoside, kaempferol-3-ObD-(6″-(E)-p-coumaroyl)-glucopyranoside and niga-ichigoside F1.

[0069] (8) The obtained polysaccharide and small molecule active substance are compounded in a ratio of 3:1 to obtain a functional ingredient composition of Rosa roxburghii.

[0070] Example 2

[0071] A functional component composition of Rosa roxburghii and a comprehensive extraction process thereof, comprising the following steps:

[0072] (1) Wash the fresh fruit of Rosa roxburghii and dry it in a 60°C forced air drying oven for 72 h, then crush it with a grinder and pass it through an 80-mesh sieve;

[0073] (2) The obtained powder was refluxed with 95% ethanol solution in a water bath at 80° C. for 3 h, filtered with suction, and the filtrate was collected. The filter residue was refluxed 3 times, filtered again with suction, and the filtrate was collected. The filter residue was naturally air-dried at room temperature until there was no ethanol smell, and the golden roxburghii residue A was obtained. The refluxed liquids from the four times were combined into solution A.

[0074] (3) Add deionized water to the residue A of golden roxburghii at a liquid-solid ratio of 1:40 (g / mL), adjust the pH of the solution to 6.5, add cellulase and hydrolyze for 150 min in a constant temperature oscillator at 60°C (the amount of cellulase is 5%, and it is dissolved in 1:3 distilled water (g / mL) before use, and water bathed at the specified temperature for 10 min), inactivate the enzyme in a water bath at 100°C for 15 min, collect the supernatant after filtration, evaporate to one-fourth to one-third of the original volume at 55°C, and collect the filtrate as residue B for later use. Use trichloroacetic acid method to remove protein, add trichloroacetic acid to the filtrate to a final concentration of 5%, stand at 5°C for 15 h, refrigerate centrifuge at 8000 r / min for 15 min, discard the precipitate, repeatedly add trichloroacetic acid to the supernatant, stand and centrifuge until there is no precipitate. The clear solution is decolorized by AB-8 macroporous resin, the volume ratio of macroporous resin to extract is 1:8, and shaken in a water bath at 40°C for 10 h. After decolorization, the filtrate was collected, and two volumes of 95% ethanol were slowly added under stirring. After being placed in a refrigerator at 5°C overnight, the precipitate was collected and redissolved in distilled water at 8000r / min. The precipitate was dialyzed with a 10kDa dialysis bag. After the dialysis was completed, the concentrate was vacuum dried at -75°C to obtain the golden roxburghii polysaccharide, with a yield of 5%.

[0075] (4) The molecular weight of the polysaccharide was determined by gel chromatography using the SEC-MALLS-RI system. A 0.15 mol / L NaCl solution (containing 0.02% NaN 3) as the mobile phase, pass through a 0.22μm water film, ultrasonically degas for 20min, and set aside. The sample was dissolved in 1mL of mobile phase, passed through a 0.22μm water film, and then tested. Detection conditions: flow rate 0.5mL / min, column temperature 25℃, injection volume 50μL, data collection 55min, refractive index increment dn / dc of 0.138mL / g. The molecular weight of the polysaccharide was measured to be 700kDa; the monosaccharide composition of the polysaccharide was determined by high-performance anion exchange chromatography-pulsed amperometry. The sample was dissolved in 1mL of deionized water, placed in a 10mL ampoule, 1mL of 4M trifluoroacetic acid was added, sealed with an alcohol burner, placed in a digestion instrument at 110℃ for 8h, and then cooled to room temperature. 1mL, 200μL, and 200μL of methanol were added to the sample three times, and each time it was blown dry with nitrogen. The dried sample was dissolved in 6 mL of ultrapure water and chromatographically analyzed after passing through a 0.22 μm water film. The specific detection conditions were: column temperature: 30 °C; flow rate: 1 mL / min; injection volume: 25 μL; mobile phase and gradient elution program: 0-15 min, 18 mM NaOH; 15-50 min, 18 mM NaOH and 100 mM CH 3 COONa. The polysaccharide was found to be composed of fucose, rhamnose, arabinose, galactose, glucose, mannose, galacturonic acid and glucuronic acid, with molar percentages of 0.88%, 6.65%, 10.31%, 26.77%, 7.03%, 1.34%, 44.98% and 2.16%, respectively.

[0076] (5) The residue B was treated with 95% ethanol aqueous solution at a liquid-to-solid ratio of 30:1, ultrasonically extracted for 50 min (60°C, 50 kHz), and centrifuged (8000 r / min, 15 min, 5°C) to obtain supernatant B and precipitated residue C. The above steps were repeated for residue C, and solution C was obtained after centrifugation.

[0077] (6) Combine solutions A, B, and C, evaporate and concentrate at 65°C, and purify using AB-8 macroporous resin. Mix distilled water and resin and slowly add them to the column, wash with distilled water, and adjust the flow rate until the filling in the column is stable. Leave at least 10 cm from the top of the column to the resin, and seal the column with distilled water. The loading volume of the mixed solution is 2 times the column volume, the flow rate is 3 mL / min, first wash with 15 times the column volume of distilled water to remove soluble sugars and proteins, and then use 95% ethanol to desorb the small molecules adsorbed on the resin, collect the desorbed liquid, rotary evaporate to obtain the concentrated liquid, transfer to a freeze dryer and dry for 60 hours to obtain the purified small molecule active substance, with a yield of 6%.

[0078] (7) LC-MS was used to detect that the main components of the small molecule active substance were ascorbic acid, Plucheoside C, catechin, epicatechin, catechin derivatives, epicatechin derivatives, prehygromycin, 1-OE-cinnamoyl-(6-arabinosyl glucose), ellagic acid-O-rhamnoside, quercetin-3-O-β-D-glucoside-6″-(E)-p-coumaryl-glucoside and quercetin F1. (8) The obtained polysaccharide was compounded with the small molecule active substance in a ratio of 1:3 to obtain a functional ingredient composition of Rosa roxburghii.

[0079] Example 3

[0080] Animal experiment on the effect of the combination of functional ingredients of golden roxburghii on relieving ulcerative colitis

[0081] 1. Animal Experiment Design

[0082] Animal grouping: Forty male C57BL / 6 mice (5-7 weeks old) weighing 20±2g were randomly divided into four groups after acclimating to the laboratory environment for 7 days, namely, control group, model group, compound group and whole fruit group, with 10 mice in each group.

[0083] Animal model: In the first week, mice in the control group and model group were free to eat AIN93G feed, and mice in the compound group and whole fruit group were free to eat AIN93G feed supplemented with 3% functional ingredient composition (the product prepared in Example 1 was recorded as compound group 1, and the product prepared in Example 2 was recorded as compound group 2) and whole fruit powder (recorded as whole fruit group), and drinking water was normal. Modeling began in the second week, and the drinking water of the model group, compound group and whole fruit group was changed to 1.5% DSS solution, and the feed was the same as the first week. Mice were prepared to be killed at any time according to the weight changes of mice in each group and the DAI score results.

[0084] 2. Sample collection

[0085] Fecal samples: Collect the feces of mice on the last day in cryopreservation tubes; when the animals are sampled, collect the cecum contents in cryopreservation tubes and store them at -80°C for testing.

[0086] Serum samples: On the 5th day after modeling, whole blood samples were obtained by drawing blood from the eyeballs. After standing at 4°C for 1 hour, the samples were centrifuged at 3000 r / min for 15 minutes. Serum samples were collected and stored at -80°C for later use.

[0087] Colon samples: After blood collection, all mice were killed by cervical dislocation, colon tissue was isolated, and the colon was measured with a ruler. The distal colon (1 cm) was cut and fixed with 4% paraformaldehyde for histopathological examination, and the remaining colon samples were stored at -80°C for future use.

[0088] 3. Test indicators, measurement methods and experimental results

[0089] (1) Daily observation of mice and disease activity index (DAI) scoring

[0090] During the experiment, all mice were weighed at regular intervals every day, and the general behavior of the mice was observed. Starting from the second week, the weight changes, feces status, and blood in the stool of the mice were recorded and scored according to the standards shown in Table 1. The average DAI score of each mouse per day was calculated according to Formula I. DAI = (weight loss percentage score + feces viscosity score + blood in the stool score) / 3 Formula I

[0091] Table 1 DAI scoring criteria

[0092]

[0093] (2) Colon length

[0094] When dissecting mice, the colon and cecum of the mice were taken out, and the length of the colon was measured and recorded using a ruler.

[0095] (3) Spleen index

[0096] When the mice were dissected, the spleens were removed and weighed, and the spleen index was calculated according to the following formula II.

[0097] Spleen index = spleen mass (mg) / body weight (g) Formula II

[0098] (4) Colon histopathological staining observation

[0099] 1) Hematoxylin-eosin staining (H&E)

[0100] The fixed colon sections were taken out and embedded in paraffin. The sections were placed in p-xylene and a certain concentration gradient of ethanol solution (70%, 80%, 90%, 100%) and soaked for a corresponding time to dewax and hydrate. The hematoxylin staining solution was usually 5 to 10 minutes. If the staining was not good, the staining time could be adjusted. After the hematoxylin staining was completed, it was rinsed with tap water for 10 minutes, and finally stained with eosin staining solution for 30 seconds to 2 minutes. Dehydration and transparency were carried out in the following order: 70% ethanol 5 minutes × 1 time; 80% ethanol 5 minutes × 1 time; 90% ethanol 5 minutes × 1 time; 100% ethanol 5 minutes × 2 times; p-xylene 5 minutes × 2 times. The neutral resin was ultrasonically treated in advance. After the section staining was completed, 20 μL of xylene was added to the middle of the tissue, and then a certain amount of neutral resin was added to the xylene. After the end, a cover glass was covered for sealing. After the slice was completely air-dried, the morphology of the tissue sample was photographed and observed under an optical microscope. The parameters and grades of colon histopathological scoring are as follows: degree of crypt damage (0 = normal, 4 = disappearance of the entire crypt and epidermal cells), degree of immune cell infiltration (0 = normal, 3 = a large number of immune cell infiltration). The histological damage score of each mouse = degree of crypt cell damage + degree of immune cell infiltration.

[0101] 2) Alcian blue staining (AB)

[0102] Take out the dewaxed tissue slices, drain the surface water slightly and put them in the wet box prepared in advance. At this time, prepare the histochemical pen and use the histochemical pen to draw a circle around the tissue to form a waterproof barrier. At this time, add 3% acetic acid solution to the tissue slices. After the addition is completed, check whether each tissue is covered by the reagent, then cover the lid of the wet box, remove the acetic acid solution after 3 minutes, and then add Alcian blue staining solution. Incubate the tissue slices at 37°C for 20 minutes. After the end, take out the tissue slices, remove the Alcian blue staining solution, quickly add acetic acid solution, knock out the staining solution after 20 seconds, and observe under an optical microscope (the blue color in the field of view is considered to be successful in staining), then add nuclear red rapid staining solution for 5 minutes and wash, and observe whether the staining is successful under an optical microscope.

[0103] After successful staining under an optical microscope, dehydrate and make transparent according to the following steps: 70% ethanol 5 min × 1 time; 80% ethanol 5 min × 1 time; 90% ethanol 5 min × 1 time; 100% ethanol 5 min × 2 times; xylene 5 min × 2 times. Ultrasonicate the neutral resin in advance, add 20 μL of xylene after the section staining is completed, drop xylene in the middle of the tissue, and then drop a certain amount of neutral resin on the xylene. After the end, cover the cover glass for sealing. After the slide is completely air-dried, take a photo of the tissue sample morphology under an optical microscope. Use image processing software to calculate the mucin area in each section, and calculate the mucin area percentage according to formula III.

[0104] Mucin area percentage (%) = mucin area / total colon tissue area × 100% Formula III

[0105] 3) Short-chain fatty acids (SCFAs) content

[0106] Fecal samples were homogenized with 4 times the volume of deionized water, centrifuged, and filtered for later use. GC-FID 6890N (Agilent Technologies, Inc., USA) was used to analyze the SCFAs content in the samples. The chromatographic column was HP-INNOWAX (No.19091N-133; 0.32 mm×0.25 μm×30 m, Agilent Technologies, Inc., USA). The GC determination conditions were as follows: FID detector, carrier gas was N 2 , flow rate is 16.2mL / min, split ratio is 10:1, detector air flow is 260mL / min, hydrogen flow is 40mL / min, tail gas flow is 20mL / min; injection port and detector temperature are both 250℃, heating program is 80℃ (hold 1min) ~ 235℃ (heating rate is 5℃ / min, hold 4min), sample injection volume is 1μL. The SCFAs content in the sample is calculated according to the calibration curve of the SCFAs standard. The standard curve equations of each standard are shown in Table 2.

[0107] Table 2 Standard curve of short chain fatty acid standards

[0108]

[0109] 4) Intestinal barrier integrity

[0110] The frozen serum samples were taken and thawed, and the contents of lipopolysaccharide (LPS) and lipopolysaccharide-binding protein (LBP) in the serum were determined using ELISA kits according to the manufacturer's instructions.

[0111] 5) Serum inflammatory factors

[0112] Frozen serum samples were taken and thawed, and the levels of TNF-α, IL-6, and IL-1β in serum were determined using ELISA kits according to the manufacturer's instructions.

[0113] 4. Experimental results

[0114] The entire experimental period lasted 11 days, of which the 8th to 11th day was the modeling period.

[0115] (1) Mouse body weight changes and DAI scores

[0116] The DSS-induced ulcerative colitis mouse model is characterized by sustained weight loss and diarrhea. The weight of the mice was recorded during the experiment, and the weight changes of the mice were observed. Figure 5 As shown. The weight of mice in each group increased slowly in the first 7 days. On the second day after DSS intervention, the weight of mice in the model group, compound group 1, compound group 2 and whole fruit group began to decrease, indicating that DSS damaged the intestines of mice. As the modeling time prolonged, the weight of mice in the model group decreased significantly, while the conditions of compound group 1, compound group 2 and whole fruit group were better than those in the model group. The results show that the whole fruit or the compound of functional components of Rosa roxburghii can alleviate the weight loss of mice caused by DSS. Although there is no significant difference in the values ​​between the two, the weight loss trend of the compound group is better than that of the whole fruit group.

[0117] When mice suffer from colitis, the severity of their inflammation can be reflected by the DAI index. Generally speaking, the higher the DAI index, the more serious the damage to the body. Figure 6 On the 11th day, the DAI scores of compound group 1 and compound group 2 were significantly lower than those of the model group and the whole fruit group (p < 0.05), and there was no significant difference between the whole fruit group and the model group. This result shows that the functional component composition of golden roxburghii can effectively reduce the disease index of mice, and has a significant effect compared with the whole fruit.

[0118] (2) Colon length

[0119] Inflammatory responses damage the intestinal structure and destroy the intestinal villi, so when the body has an inflammatory response, the mouse colon will shorten, and the more severe the inflammatory response, the more the colon shortens. Figure 7The average colon length of mice in the control group was 5.5 cm, and the average colon length of mice in the model group was 4.3 cm, which was significantly shorter than that of the normal group (p < 0.01), indicating that DSS had a serious damaging effect on the intestines of mice. The average colon lengths of mice in compound group 1 and compound group 2 were 5.2 cm and 5.3 cm, respectively, which were significantly different from the model group (p < 0.01), while the colon length of mice in the whole fruit group was 4.5 cm, which was not significantly different from the model group. This shows that compared with the whole fruit, the functional component compound has a more significant alleviating effect on the shortening of the mouse colon (p < 0.01).

[0120] (3) Spleen index

[0121] The spleen is the largest immune organ in the human body. When the body has an inflammatory response, it will induce an immune response, leading to splenomegaly. Splenomegaly is associated with splenic macrophage infiltration. Figure 8 It can be seen that after DSS induction, mice will have immune disorders, thereby triggering ulcerative colitis, resulting in a significant increase in the spleen index of mice (p < 0.01), while the spleen index of mice in compound group 1 and compound group 2 was significantly lower than that in the model group (p < 0.01), and there was no significant difference between them and the control group, indicating that the functional ingredient compound can effectively alleviate the spleen enlargement caused by DSS in mice, while the whole fruit has no obvious effect.

[0122] (4) Colon histopathological observation and scoring

[0123] The histopathological score takes into account the degree of loss of structural integrity, the presence of crypts, crypt destruction, and changes in the mucosal surface. When ulcerative colitis occurs in the body, neutrophils are recruited to the site of inflammation and are found within the intestinal crypts and at the bottom of the ulcers, forming crypt abscesses, while the goblet cell membrane shrinks or even becomes depleted, resulting in reduced mucin expression and impaired intestinal mucosal barrier. Fig. 9 The H&E staining results of Figure A show that the epithelial cells and crypt structures of the colon tissue of healthy mice are intact, without inflammatory cell infiltration, while the colon of the model group mice showed irregular morphology, most of the crypt structures disappeared, goblet cells were damaged, and inflammatory cells were severely infiltrated. The colon tissue of the whole fruit group mice was similar to that of the model group, while the colon tissue of the mice in the compound group 1 and compound group 2 were relatively intact. The colon tissue ulcers of each group were quantified using the colon tissue pathology scoring standard. The results are shown in Figure 2. Fig. 9 As shown in C, this result shows that the functional component compound can alleviate the symptoms of DSS-induced ulcerative colitis in mice. At the same time, the AB staining ( Fig. 9 B) The percentage of mucin area in each group, the results are as follows Fig. 9In middle D, although there was no significant difference in the values ​​among the model group, compound group 1, compound group 2, and whole fruit group, the trend among the groups showed that the compound group had greater potential to alleviate the reduction in mucin expression.

[0124] (5) SCFAs content

[0125] Short-chain fatty acids can reduce inflammation by maintaining intestinal integrity and regulating immune cells, thereby reducing the occurrence and development of ulcerative colitis. Fig.10 As shown in the results, the total short-chain fatty acid content in the cecal contents and feces of the model group was significantly lower than that of the control group (p < 0.05), while the functional ingredient compound could significantly increase the total short-chain fatty acid content in the cecal contents and feces of mice with ulcerative colitis (p < 0.05), and it was mainly reflected in butyrate. It is reported that butyrate not only provides an important energy source for cell growth, but also can enhance the integrity of the intestinal barrier, reduce intestinal permeability, and prevent intestinal bacterial migration. This result shows that the functional ingredient compound can relieve intestinal inflammation by promoting the production of short-chain fatty acids.

[0126] (6) Intestinal barrier integrity

[0127] Ulcerative colitis can lead to increased intestinal permeability, causing intestinal leakage, which allows the endotoxin LPS in the outer membrane of most Gram-negative bacteria to pass through the intestinal mucosa and enter the blood circulation. The body's LBP can recognize LPS and trigger an inflammatory response through a series of pathways. Therefore, changes in intestinal permeability can be determined by comparing changes in serum LBP and LPS levels. Fig.11 The results showed that the levels of LBP and LPS in the serum of the model group were significantly higher than those in the control group (p < 0.01), indicating that the intestinal permeability of the mice in this group was greatly increased and the intestinal barrier was damaged. The levels of LBP and LPS in the serum of the mice in the compound group 1 and compound group 2 were significantly lower than those in the model group (p < 0.01), and lower than those in the whole fruit group, indicating that the functional ingredient compound can effectively alleviate the intestinal barrier damage caused by DSS and maintain intestinal permeability.

[0128] (7) Serum inflammatory factors

[0129] TNF-α, IL-6, and IL-1β are considered to be proinflammatory cytokines in the pathogenesis of ulcerative colitis and are associated with the severity of inflammation. Fig.12The results showed that the levels of TNF-α, IL-6 and IL-1β in the serum of the model group mice were significantly higher than those in the control group (p < 0.01), while the levels of these three inflammatory factors in the serum of the compound group 1, compound group 2 and whole fruit group were significantly reduced (p < 0.01), and the trend of the reduction of TNF-α and IL-1β in the compound group was more obvious. This result shows that the functional component composition of Rosa roxburghii can effectively relieve ulcerative colitis caused by DSS in mice, and the relief effect is better than that of the whole Rosa roxburghii fruit.

[0130] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A functional ingredient composition of Rosa roxburghii having the function of relieving ulcerative colitis, characterized in that: Including roxburghii roxburghii polysaccharides and roxburghii ... small molecule active substances; The mass ratio of the roxburghii roxburghii polysaccharide to the roxburghii roxburghii small molecule active substance is 1-3:1-3; The preparation method of the roxburghii roxburghii polysaccharide and the roxburghii roxburghii small molecule active substance comprises the following steps: The fresh fruit of Rosa roxburghii is dried and crushed, and then refluxed with an ethanol aqueous solution, the reflux liquid is solution A, and ethanol is removed from the residue; during the reflux, the volume percentage of the ethanol aqueous solution is 70% to 95%; The residue after removing ethanol is extracted with an aqueous solution containing cellulase to obtain enzymolysis residue and an extract, and after removing protein and pigment impurities from the extract, polysaccharide is collected by an alcohol precipitation method to obtain golden roxburghii polysaccharide; during the extraction, the solid-liquid ratio of the residue after removing ethanol and the aqueous solution containing cellulase is 1g:20-40mL; the final mass percentage of the cellulase is 1%-5%; the enzymolysis temperature of the cellulase is 40-60°C, and the enzymolysis time of the cellulase is 80-150min; during the alcohol precipitation, the volume percentage of the alcohol solution is 80%-95%; The enzymatic residue is subjected to ultrasonic extraction with an ethanol aqueous solution, and the extract is collected to obtain a solution B; The solution A and the solution B are mixed and purified, and after removing water, a small molecule active substance of Rosa roxburghii is obtained; the method for mixing and purifying the solution A and the solution B is purification using a macroporous resin; In the macroporous resin purification method, the loading volume of the mixed solution of solution A and solution B is 0.5 to 2 times the column volume, the flow rate is 1 to 3 mL / min, the detergent is 8 to 15 times the column volume of distilled water, and the desorbent is an ethanol aqueous solution with a volume percentage of 70% to 95%.

2. The functional ingredient composition of Rosa roxburghii according to claim 1, characterized in that: The roxburghii roxburghii polysaccharide comprises the following components in molar percentage: 0-1% fucose, 6-7% rhamnose, 10-11% arabinose, 26-27% galactose, 7-8% glucose, 1-2% mannose, 44-45% galacturonic acid and 2-3% glucuronic acid.

3. The functional ingredient composition of Rosa roxburghii according to claim 1, characterized in that: The small molecule active substances of golden roxburghii include ascorbic acid, Plucheoside C, catechin, epicatechin, catechin derivatives, epicatechin derivatives, prehygromycin, 1-OE-cinnamoyl-(6-arabinosyl glucose), ellagic acid-O-rhamnoside, quercetin-3-O-β-D-glucoside-6″-(E)-p-coumaryl-glucoside and chokeberry glycoside F1.

4. A method for preparing the functional ingredient composition of Rosa roxburghii according to any one of claims 1 to 3, characterized in that: The following steps are involved: The fresh fruit of Rosa roxburghii is dried and crushed, and then refluxed with an ethanol aqueous solution, the reflux liquid is solution A, and ethanol is removed from the residue; during the reflux, the volume percentage of the ethanol aqueous solution is 70% to 95%; The residue after removing ethanol is extracted with an aqueous solution containing cellulase to obtain enzymolysis residue and an extract, and after removing protein and pigment impurities from the extract, polysaccharide is collected by an alcohol precipitation method to obtain golden roxburghii polysaccharide; during the extraction, the solid-liquid ratio of the residue after removing ethanol and the aqueous solution containing cellulase is 1g:20-40mL; the final mass percentage of the cellulase is 1%-5%; the enzymolysis temperature of the cellulase is 40-60°C, and the enzymolysis time of the cellulase is 80-150min; During alcohol precipitation, the volume percentage of the alcohol solution is 80% to 95%; The enzymatic residue is subjected to ultrasonic extraction with an ethanol aqueous solution, and the extract is collected to obtain a solution B; The solution A and the solution B are mixed and purified, and after removing water, a small molecule active substance of Rosa roxburghii is obtained; The method for purifying the mixture of solution A and solution B is purification using a macroporous resin; In the purification method of the macroporous resin, the loading volume of the mixed solution of solution A and solution B is 0.5 to 2 times the column volume, the flow rate is 1 to 3 mL / min, the detergent is 8 to 15 times the column volume of distilled water, and the desorbent is an ethanol aqueous solution with a volume percentage of 70% to 95%; The roxburghii roxburghii polysaccharide and the roxburghii roxburghii small molecule active substance are compounded to obtain the roxburghii roxburghii functional ingredient composition.

5. The method for preparing the functional component composition of Rosa roxburghii according to claim 4, characterized in that: During ultrasonic extraction of ethanol aqueous solution, the volume percentage of the ethanol aqueous solution is 70% to 95%, the liquid-to-solid ratio of the enzymatic hydrolysis residue to the ethanol aqueous solution is 1:10 to 30, the time of ultrasonic extraction of the ethanol aqueous solution is 20 to 50 minutes, the temperature of ultrasonic extraction of the ethanol aqueous solution is 40 to 60° C., and the frequency of the ultrasound is 30 to 50 kHz.